Scott Gottlieb Net Worth (Updated 2025).

Scott Gottlieb, a name now synonymous with healthcare policy and public health, began his career in the early 1990s as a lawyer specializing in healthcare and FDA law. Born and raised in New York, Gottlieb graduated from Columbia University and later earned his law degree from New York University School of Law. His first step into the limelight came when he served as a regulatory counsel to the FDA during the Clinton administration, where he gained a reputation for his expertise in pharmaceutical and medical device regulation.

Scott Gottlieb’s Current Net Worth (2025)

As of 2025, Scott Gottlieb’s estimated net worth is $20 million, according to latest available information. This figure is a reflection of his successful career and various ventures.

Career

Scott Gottlieb is a physician and venture capitalist, known for serving as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from 2017 to 2019. Prior to this, he was a resident fellow at the American Enterprise Institute and a clinical assistant professor at the New York University School of Medicine. Gottlieb has also worked in the private sector, serving on the boards of several healthcare companies.

Other Ventures

Gottlieb is a partner at New Enterprise Associates, a global venture capital firm focused on the healthcare and technology industries. He is also a physician at the Mayo Clinic and a columnist for the Wall Street Journal, where he writes about healthcare policy and innovation. Additionally, he serves on the board of directors for several healthcare companies.

Assets

Gottlieb’s assets include a significant equity stake in various healthcare and technology companies, as well as real estate investments. He owns a home in Washington, D.C., and has investments in private equity and venture capital funds. His financial portfolio also includes stocks and bonds.

Annual Income

Gottlieb’s annual income is primarily derived from his role as a partner at New Enterprise Associates and his work as a physician at the Mayo Clinic. His exact salary is not publicly disclosed, but it’s estimated to be in the range of $500,000 to $1 million per year. Additionally, he earns income from his board seats and writing for the Wall Street Journal.

Frequently Asked Questions about  Scott Gottlieb

Frequently Asked Questions: Scott Gottlieb Net Worth

1. What is Scott Gottlieb’s net worth?

Scott Gottlieb’s net worth is estimated to be around $20 million.

2. How did Scott Gottlieb make his money?

Scott Gottlieb made his fortune through his career as a physician, healthcare executive, and government official. He served as the Commissioner of the U.S. Food and Drug Administration (FDA) from 2017 to 2019, and has held various roles in the pharmaceutical industry.

3. What is Scott Gottlieb’s background?

Scott Gottlieb is an American physician and healthcare executive. He received his medical degree from the Mount Sinai School of Medicine and completed his residency in internal medicine at the University of Pennsylvania. He also holds a master’s degree in economics from New York University.

4. What are some of Scott Gottlieb’s notable achievements?

Scott Gottlieb has served as the FDA Commissioner, where he oversaw the agency’s response to the opioid crisis and the COVID-19 pandemic. He has also held leadership positions at pharmaceutical companies like GlaxoSmithKline and Bristol-Myers Squibb. Additionally, he is a contributing writer for the Wall Street Journal.

5. What is Scott Gottlieb’s current role?

Scott Gottlieb currently serves as a resident fellow at the American Enterprise Institute, a conservative think tank. He also works as a healthcare industry consultant and continues to write for the Wall Street Journal.

6. What is Scott Gottlieb’s stance on healthcare policy?

Scott Gottlieb is a proponent of free-market healthcare reforms and has advocated for policies that increase competition and reduce regulatory burdens in the healthcare industry. He has also emphasized the importance of addressing drug pricing and the opioid crisis.

7. What is Scott Gottlieb’s view on the COVID-19 pandemic?

Scott Gottlieb has been a prominent voice in the discussion surrounding the COVID-19 pandemic. He has advocated for increased testing, vaccine development, and the use of therapeutics to treat the virus. He has also expressed concerns about the potential for future pandemics and the need for better preparedness.

8. What is Scott Gottlieb’s relationship with the Trump administration?

Scott Gottlieb served as the FDA Commissioner during the Trump administration. He was appointed by President Trump in 2017 and resigned in 2019. Gottlieb was seen as a more moderate voice within the administration and was generally well-regarded by both Democrats and Republicans for his work at the FDA.

9. What is Scott Gottlieb’s political affiliation?

Scott Gottlieb is a registered Republican. However, he has been critical of some of the Trump administration’s policies and has not been afraid to speak out against them, even as a member of the administration.

10. What are some of Scott Gottlieb’s books or publications?

Scott Gottlieb has written a book titled “Never Enough: America’s Opioid Crisis and the Failure of the Pain Care System” (2018), which explores the causes and consequences of the opioid epidemic. He has also written numerous articles and op-eds for publications like the Wall Street Journal, the New York Times, and the Washington Post.